We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Amsterdam Molecular Therapeutics Enters Research Collaboration with the University of Barcelona

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Amsterdam Molecular Therapeutics Enters Research Collaboration with the University of Barcelona"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Amsterdam Molecular Therapeutics BV (AMT) has announced that it will undertake collaborative research activities in the area of gene regulation of fatty acid oxidation and obesity with the University of Barcelona, Spain.

The research group will be led by Professor Fausto G. Hegardt, Professor of Biochemistry and head of the Laboratory at the School of Pharmacy of the University of Barcelona.

The research will focus on development of a gene therapy capable of regulating mitochondrial fatty acid metabolism and insulin resistance.

The collaboration will initially aim to demonstrate the safety and efficacy of the product various preclinical models. If successful the product will be taken into clinical development and commercialization.